<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04851847</url>
  </required_header>
  <id_info>
    <org_study_id>D20190472-P</org_study_id>
    <nct_id>NCT04851847</nct_id>
  </id_info>
  <brief_title>A Clinical Trial to Evaluate the Safety and Effectiveness of Resorbable Collagen Membrane - MatrixflexTM</brief_title>
  <official_title>A Clinical Trial to Evaluate the Safety and Effectiveness of Resorbable Collagen Membrane - MatrixflexTM for the Treatment of Periodontal Intrabony Defects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Collagen Matrix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Collagen Matrix</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, single blind, parallel-arm, multi-center, non-inferior clinical trial.&#xD;
      174 patients are recruited in total, and they are treated by Guided Tissue Regeneration&#xD;
      (GTR). The patients are split in to two groups evenly: 87 in the experimental group and 87 in&#xD;
      the control group.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 10, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 20, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change of CAL at 12 weeks after surgery</measure>
    <time_frame>12 weeks</time_frame>
    <description>Assessment of clinical attachment level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of CAL at 24 weeks after surgery</measure>
    <time_frame>24 weeks</time_frame>
    <description>Assessment of clinical attachment level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of PD at 12 weeks after surgery</measure>
    <time_frame>12 weeks</time_frame>
    <description>Assessment of Probing Depth</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of PD at 24 weeks after surgery</measure>
    <time_frame>24 weeks</time_frame>
    <description>Assessment of Probing Depth</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The ratio between Baseline and gingival recession (GR) at 12 weeks after surgery.</measure>
    <time_frame>12 weeks</time_frame>
    <description>Effect on Gingival recession</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The ratio between Baseline and gingival recession (GR) at 24 weeks after surgery.</measure>
    <time_frame>24 weeks</time_frame>
    <description>Effect on Gingival recession</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">174</enrollment>
  <condition>Periodontal Diseases</condition>
  <condition>Intrabony Defects</condition>
  <condition>Guided Tissue Regeneration</condition>
  <arm_group>
    <arm_group_label>MatrixflexTM resorbable collagen membrane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental arm using the Matrixflex Resorbable Collagen Membrane for treatment of periodontal intrabony defects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group membrane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control arm using the Comparator Xenograft Resorbable Collagen Membrane or treatment of periodontal intrabony defects</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Guided Tissue Regeneration (GTR)</intervention_name>
    <description>Use of resorbable collagen membrane to treat periodontal intrabony defects.</description>
    <arm_group_label>MatrixflexTM resorbable collagen membrane</arm_group_label>
    <arm_group_label>control group membrane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Aged 18 to 65 years, male or female;&#xD;
&#xD;
          2. patients were clinically diagnosed with chronic periodontitis according to the&#xD;
             international classification of periodontal disease in 1999;&#xD;
&#xD;
          3. Only solitary lesion site requires surgical treatment and must meet the following&#xD;
             criteria:&#xD;
&#xD;
               1. The baseline PD≥7 mm ;&#xD;
&#xD;
               2. After debridement during operation, the defect of the vertical bone at the&#xD;
                  adjacent surface ≥4mm, and at least one alveolar buccal wall can be detected;&#xD;
&#xD;
               3. The wideness of the keratinized gingiva≥2 mm;&#xD;
&#xD;
               4. Based on the X-Ray image, the dental crowns at the bottom of the bone socket&#xD;
                  should be at least 3mm;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. The test tooth has open surgical debridement history within the most recent one years;&#xD;
&#xD;
          2. Known allergy to collagen of animal origin;&#xD;
&#xD;
          3. Clinical or radiographic signs of untreated acute infection at the surgical site,&#xD;
             apical pathology, root fracture, severe root irregularities, cemental pearls,&#xD;
             cemento-enamel projections not easily removed by odontoplasty, untreated carious&#xD;
             lesions at the cemento-enamel junction (CEJ) or on the root surface, subgingival&#xD;
             restorations and/or restorations with open margins at or below the CEJ;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mohamed Moawad</last_name>
    <phone>2014051477</phone>
    <phone_ext>348</phone_ext>
    <email>mmoawad@collagenmatrix.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Peggy Hansen</last_name>
    <phone>201-405-1477</phone>
    <phone_ext>304</phone_ext>
    <email>phansen@collagenmatrix.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiefei Wu</last_name>
      <phone>18501785729</phone>
      <email>jaffa@maturesh.com</email>
    </contact>
    <investigator>
      <last_name>Rong Shu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 14, 2021</study_first_submitted>
  <study_first_submitted_qc>April 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2021</study_first_posted>
  <last_update_submitted>June 15, 2021</last_update_submitted>
  <last_update_submitted_qc>June 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>resorbable collagen membrane</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

